CoChat

Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression

Open access
Freeman, Marlene P., Papakostas, George I., Hoeppner, Bettina, Mazzone, Erica, Judge, Heidi, Cusin, Cristina, Mathew, Sanjay, Sanacora, Gerard, Iosifescu, Dan, DeBattista, Charles, Trivedi, Madhukar H., Fava, Maurizio · 2019 · Journal of Psychiatric Research
Cited by 69

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Background: While ketamine has been increasingly studied for treatment resistant depression (TRD), the impact of sex differences on treatment outcomes has not been well studied. The objective was to ascertain whether there were differences in response to a single administration of ketamine for TRD between men and women, and between pre- and post-menopausal women. Methods: A randomized, double-blind, placebo-controlled trial (N=99; N=50 male; N=49 female) was conducted to investigate the efficacy of intravenous ketamine versus active placebo as augmentation of antidepressant therapy for TRD. Patients were assigned to one of five arms; one-time administration of ketamine of varying doses (i.e., 0.1, 0.2, 0.5, and 1.0 mg/kg), and one group receiving active placebo (intravenous midazolam). A priori-planned analyses were conducted to compare responses between women and men, as well pre- vs. postmenopausal women. Results: Analyses demonstrated no significant differences between women and men in terms of treatment response (F(1,80)=0.06, p=0.80). There were no significant differences in the frequency of adverse effects (AEs) reported by those assigned to ketamine treatment groups (p>0.21 for all AEs reported more than once), although women reported more headaches (12% vs. 6%, p=0.30) and nausea (10% vs. 6%, p=0.47). In comparing pre- vs. postmenopausal women, no differences in efficacy were observed (F(1,76)=0.36, p=0.55). Conclusions: Results do not support differential efficacy or tolerability of ketamine for the treatment of TRD between women and men, nor based on menopause status among women. However, larger trials with these a priori aims are needed to confirm these results.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jpsychires.2019.01.010

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 69

Metadata

Authors
Freeman, M. P., Papakostas, G. I., Hoeppner, B., Mazzone, E., Judge, H., Cusin, C., Mathew, S., Sanacora, G., Iosifescu, D., DeBattista, C., Trivedi, M. H., & Fava, M.
Venue
Journal of Psychiatric Research
Publisher
Elsevier BV
Published
2019-03
Volume
110
Pages
166-171
ISSN
0022-3956 (ISSN-L)
OpenAlex
W2908836405
Cited by
69
References
10
FWCI
4.70
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression. https://app.cochat.ai/papers/10.1016/j.jpsychires.2019.01.010
The paper
Freeman, M. P., Papakostas, G. I., Hoeppner, B., Mazzone, E., Judge, H., Cusin, C., Mathew, S., Sanacora, G., Iosifescu, D., DeBattista, C., Trivedi, M. H., & Fava, M. (2019). Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression. Journal of Psychiatric Research. https://doi.org/10.1016/j.jpsychires.2019.01.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.